Twist Bioscience Corporation
TWST US90184D1000
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -42% | -71% | 55% | 34% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Werner Robert F. DIR |
32.19 USD |
2,041 Sold |
65,694 USD |
06/10/2025 | 06/10/2025 |
| Green Paula VP |
32.19 USD |
9,724 Sold |
312,986 USD |
06/10/2025 | 06/10/2025 |
| Leproust Emily M. CEO |
32.19 USD |
31,348 Sold |
1,008,998 USD |
06/10/2025 | 06/10/2025 |
| Finn Patrick John PR |
32.19 USD |
23,747 Sold |
764,345 USD |
06/10/2025 | 06/10/2025 |
| Cho Dennis O |
32.19 USD |
3,876 Sold |
124,757 USD |
06/10/2025 | 06/10/2025 |
| Laponis Adam CFO |
32.19 USD |
5,875 Sold |
189,099 USD |
06/10/2025 | 06/10/2025 |
| Green Paula VP |
29.16 USD |
140 Sold |
4,083 USD |
02/10/2025 | 02/10/2025 |
| Finn Patrick John PR |
29.16 USD |
206 Sold |
6,007 USD |
02/10/2025 | 02/10/2025 |
| Cho Dennis O |
29.16 USD |
124 Sold |
3,616 USD |
02/10/2025 | 02/10/2025 |
| Finn Patrick John PR |
29.16 USD |
206 Sold |
6,007 USD |
02/10/2025 | 02/10/2025 |